Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
Authors
Keywords
-
Journal
Journal of Parkinsons Disease
Volume -, Issue -, Pages 1-9
Publisher
IOS Press
Online
2019-03-23
DOI
10.3233/jpd-181535
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease
- (2016) Shamik Bhattacharyya et al. MOVEMENT DISORDERS
- The incidence of Parkinson's disease in the North-East of England
- (2013) G. W. Duncan et al. AGE AND AGEING
- Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration
- (2012) X. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- The MoCA: Well-suited screen for cognitive impairment in Parkinson disease
- (2010) J. C. Dalrymple-Alford et al. NEUROLOGY
- Acute homocysteine rise after repeated levodopa application in patients with Parkinson’s disease
- (2010) Thomas Müller et al. PARKINSONISM & RELATED DISORDERS
- Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
- (2009) H. Chen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death
- (2009) Ranjana Poddar et al. JOURNAL OF NEUROCHEMISTRY
- Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study
- (2009) Maria C. Rodriguez-Oroz et al. MOVEMENT DISORDERS
- Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia
- (2009) Stefano Zoccolella et al. MOVEMENT DISORDERS
- Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients
- (2008) Tammaryn Lashley et al. ACTA NEUROPATHOLOGICA
- Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
- (2008) Michael A. Schwarzschild ARCHIVES OF NEUROLOGY
- Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients
- (2008) Paolo Barone et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Uric acid associates with cognition in Parkinson's disease
- (2008) Tua Annanmaki et al. PARKINSONISM & RELATED DISORDERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started